Stockreport

Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris [Yahoo! Finance]

Biofrontera Inc.  (BFRI) 
PDF Biofrontera Inc. • Phase 2b study demonstrated greater reductions in inflammatory acne lesions with Ameluz ® PDT versus vehicle • 3-hour incubation regimen identifi [Read more]